Drug
Trichloroacetic acid
Trichloroacetic acid is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_4
2
40%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed360%
unknown120%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue
NCT06281353
withdrawnphase_2
Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test
NCT06188104
completednot_applicable
New Treatment of Alopecia Areata
NCT05594316
completedphase_4
Cantharone for the Treatment of Perenial Warts
NCT03625960
unknownphase_4
Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid
NCT03153852
Clinical Trials (5)
Showing 5 of 5 trials
NCT06281353Phase 2
The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue
NCT06188104Phase 2
Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test
NCT05594316Not Applicable
New Treatment of Alopecia Areata
NCT03625960Phase 4
Cantharone for the Treatment of Perenial Warts
NCT03153852Phase 4
Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5